相似文献
1
3/ drives aggressive breast cancer progression by down-regulation of GATA3 expression.
Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):3169-3174. doi: 10.1073/pnas.1701690114. Epub 2017 Mar 3.
2
The Transcriptional Repressor ZNF503/Zeppo2 Promotes Mammary Epithelial Cell Proliferation and Enhances Cell Invasion.
J Biol Chem. 2015 Feb 6;290(6):3803-13. doi: 10.1074/jbc.M114.611202. Epub 2014 Dec 23.
3
Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth.
Breast Cancer Res. 2014 Dec 6;16(6):491. doi: 10.1186/s13058-014-0491-x.
4
GATA3 targets semaphorin 3B in mammary epithelial cells to suppress breast cancer progression and metastasis.
Oncogene. 2017 Oct 5;36(40):5567-5575. doi: 10.1038/onc.2017.165. Epub 2017 Jun 5.
5
GATA3 cooperates with PARP1 to regulate CCND1 transcription through modulating histone H1 incorporation.
Oncogene. 2014 Jun 12;33(24):3205-16. doi: 10.1038/onc.2013.270. Epub 2013 Jul 15.
6
GATA3 recruits UTX for gene transcriptional activation to suppress metastasis of breast cancer.
Cell Death Dis. 2019 Nov 4;10(11):832. doi: 10.1038/s41419-019-2062-7.
7
GATA3 protein as a MUC1 transcriptional regulator in breast cancer cells.
Breast Cancer Res. 2006;8(6):R64. doi: 10.1186/bcr1617.
8
ELK3-GATA3 axis modulates MDA-MB-231 metastasis by regulating cell-cell adhesion-related genes.
Biochem Biophys Res Commun. 2018 Apr 6;498(3):509-515. doi: 10.1016/j.bbrc.2018.03.011. Epub 2018 Mar 3.
9
Shift in GATA3 functions, and GATA3 mutations, control progression and clinical presentation in breast cancer.
Breast Cancer Res. 2014 Nov 20;16(6):464. doi: 10.1186/s13058-014-0464-0.
10
GATA3 Truncating Mutations Promote Cistromic Re-Programming In Vitro, but Not Mammary Tumor Formation in Mice.
J Mammary Gland Biol Neoplasia. 2019 Sep;24(3):271-284. doi: 10.1007/s10911-019-09432-4. Epub 2019 Jun 19.
引用本文的文献
1
Molecular analysis of lung adenocarcinomas from the SAFIR02-Lung cohort reveals new metastasis-associated copy-number alterations including frequent mutant-specific KRAS-allelic imbalance and identifies CDKN2A homozygous deletions as an independent biomarker of poor prognosis.
Br J Cancer. 2025 Sep 11. doi: 10.1038/s41416-025-03183-2.
2
Vertical transmission of Leishmania donovani with placental degeneration in the pregnant mouse model of visceral leishmaniasis.
PLoS Negl Trop Dis. 2025 Jun 9;19(6):e0012650. doi: 10.1371/journal.pntd.0012650. eCollection 2025 Jun.
3
Cardiac differentiation roadmap for analysis of plasticity and balanced lineage commitment.
Stem Cell Reports. 2025 Mar 11;20(3):102422. doi: 10.1016/j.stemcr.2025.102422. Epub 2025 Feb 27.
4
Unveiling GATA3 Signaling Pathways in Health and Disease: Mechanisms, Implications, and Therapeutic Potential.
Cells. 2024 Dec 22;13(24):2127. doi: 10.3390/cells13242127.
5
Luminal epithelial cells integrate variable responses to aging into stereotypical changes that underlie breast cancer susceptibility.
Elife. 2024 Nov 15;13:e95720. doi: 10.7554/eLife.95720.
6
Genome-wide Cas9-mediated screening of essential non-coding regulatory elements via libraries of paired single-guide RNAs.
Nat Biomed Eng. 2024 Jul;8(7):890-908. doi: 10.1038/s41551-024-01204-8. Epub 2024 May 22.
7
Non-invasive biomarkers for early diagnosis of pancreatic cancer risk: metabolite genomewide association study based on the KCPS-II cohort.
J Transl Med. 2023 Dec 4;21(1):878. doi: 10.1186/s12967-023-04670-x.
8
MicroRNA-495: a therapeutic and diagnostic tumor marker.
J Mol Histol. 2023 Dec;54(6):559-578. doi: 10.1007/s10735-023-10159-0. Epub 2023 Sep 28.
9
Prognostic and Immune Infiltration Value of Proteasome Assembly Chaperone (PSMG) Family Genes in Lung Adenocarcinoma.
Int J Med Sci. 2023 Jan 1;20(1):87-101. doi: 10.7150/ijms.78590. eCollection 2023.
10
Novel Potential Therapeutic Targets of PTPN Families for Lung Cancer.
J Pers Med. 2022 Nov 23;12(12):1947. doi: 10.3390/jpm12121947.
本文引用的文献
1
Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells.
Nature. 2015 Oct 1;526(7571):131-5. doi: 10.1038/nature15260. Epub 2015 Sep 23.
2
Dysfunction of the Reciprocal Feedback Loop between GATA3- and ZEB2-Nucleated Repression Programs Contributes to Breast Cancer Metastasis.
Cancer Cell. 2015 Jun 8;27(6):822-36. doi: 10.1016/j.ccell.2015.04.011. Epub 2015 May 28.
3
The long noncoding RNA SPRY4-IT1 increases the proliferation of human breast cancer cells by upregulating ZNF703 expression.
Mol Cancer. 2015 Feb 22;14:51. doi: 10.1186/s12943-015-0318-0.
4
The Transcriptional Repressor ZNF503/Zeppo2 Promotes Mammary Epithelial Cell Proliferation and Enhances Cell Invasion.
J Biol Chem. 2015 Feb 6;290(6):3803-13. doi: 10.1074/jbc.M114.611202. Epub 2014 Dec 23.
5
GATA3 mutations define a unique subtype of luminal-like breast cancer with improved survival.
Cancer. 2014 May 1;120(9):1329-37. doi: 10.1002/cncr.28566. Epub 2014 Jan 29.
6
High expression of ZNF703 independent of amplification indicates worse prognosis in patients with luminal B breast cancer.
Cancer Med. 2013 Aug;2(4):437-46. doi: 10.1002/cam4.88. Epub 2013 May 22.
7
Cell type-selective expression of the zinc finger-containing gene Nolz-1/Zfp503 in the developing mouse striatum.
Neurosci Lett. 2013 Aug 26;548:44-9. doi: 10.1016/j.neulet.2013.05.020. Epub 2013 May 16.
8
GATA3 mutations found in breast cancers may be associated with aberrant nuclear localization, reduced transactivation and cell invasiveness.
Horm Cancer. 2013 Jun;4(3):123-39. doi: 10.1007/s12672-013-0138-x. Epub 2013 Feb 22.
9
GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression.
Nat Cell Biol. 2013 Feb;15(2):201-13. doi: 10.1038/ncb2672. Epub 2013 Jan 27.
10
Comprehensive molecular portraits of human breast tumours.
Nature. 2012 Oct 4;490(7418):61-70. doi: 10.1038/nature11412. Epub 2012 Sep 23.
Zotero 插件